<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00213655</url>
  </required_header>
  <id_info>
    <org_study_id>2003/081/HP</org_study_id>
    <nct_id>NCT00213655</nct_id>
  </id_info>
  <brief_title>URO-BCG-4 : Bladder Tumors Immunotherapy</brief_title>
  <official_title>Clinical Evaluation of Maintenance BCG Immunotherapy in Superficial Bladder Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of maintenance BCG immunotherapy (dose 27 mg) in superficial bladder tumors. Two
      randomized arms (every 3 or 6 months) will be studied for a population of 300 patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BCG maintenance immunotherapy 1/3 dose : 27 mg two randomized arms : 3 or 6 months for 36
      months clinical side effects according to OMS score efficacy regarding recurrence : cytology
      and cystoscopy PSA, leucocyturia and N-ramp gene evaluation
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tumoral response</measure>
    <time_frame>Month 36</time_frame>
    <description>Tumoral response assessed at M36</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tumoral response</measure>
    <time_frame>Month 24</time_frame>
    <description>Tumoral response assessed at M24</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">146</enrollment>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>Daily instillation of BCG for 3 weeks then every 6 months</arm_group_label>
    <description>Effect of daily instillation of BCG (27 mg) for 3 weeks then one instillation of BCG (27 mg) every 6 months for 36 months on bladder tumor recurrence</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Daily instillation of BCG for 2 weeks then every 3 months</arm_group_label>
    <description>Effect of daily instillation of BCG (27 mg) for 2 weeks then one instillation of BCG (27 mg) every 3 months for 36 months on bladder tumor recurrence</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>bladder tumor recurrence</intervention_name>
    <description>bladder tumor recurrence assessed by clinical and biological exams</description>
    <arm_group_label>Daily instillation of BCG for 3 weeks then every 6 months</arm_group_label>
    <arm_group_label>Daily instillation of BCG for 2 weeks then every 3 months</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Bladder Cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ta and T1 bladder tumors

        Exclusion Criteria:

          -  BCG contra-indications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian PFISTER, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charles Nicolle, University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>July 30, 2014</last_update_submitted>
  <last_update_submitted_qc>July 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

